Contribution · Application — Research

AI for Literature and Systematic Review

A systematic review traditionally takes 12-18 months and a team of five. LLMs can compress the abstract-screening and data-extraction phases to weeks — but systematic review methodology is rigorous for a reason. The Cochrane and PRISMA frameworks exist because unreviewed literature synthesis misinforms clinical practice and policy. LLMs accelerate; humans adjudicate; the published review is signed by humans accountable for its conclusions.

Application facts

Domain
Research
Subdomain
Evidence synthesis
Example stack
Claude Opus 4.7 for abstract screening and data extraction · Rayyan / Covidence for systematic review workflow · LlamaIndex over PubMed, Scopus, Embase, CENTRAL · Pydantic schemas for PICO extraction · Dual-review reconciliation UI

Data & infrastructure needs

  • Literature corpora (PubMed, Cochrane CENTRAL, Scopus)
  • PICO / inclusion-exclusion criteria
  • Risk-of-bias tools (Cochrane RoB 2, ROBINS-I)
  • Prior review protocols

Risks & considerations

  • Missing relevant studies — LLM false negatives on screening
  • Extraction errors for numerical data (OR, HR, CI)
  • Publication bias amplification
  • Hallucinated citations — every reference must be verified
  • Methodological drift from accepted frameworks (Cochrane, PRISMA)

Frequently asked questions

Is AI for systematic review safe?

With dual-LLM + human adjudication at each step: yes, and it materially speeds up what is otherwise a year-long process. Follow PRISMA 2020 and disclose AI use in your methods section. Human reviewers sign; AI assists.

What LLM is best?

Claude Opus 4.7 with long context handles full-text extraction better than short-context models. Pair with deterministic tools for numerical extraction (meta-analysis data). Never trust the LLM alone on numbers — always verify.

Regulatory concerns?

Research ethics (ICMR, IRB) for the underlying research. Journal disclosure policies (ICMJE) require AI disclosure. Copyright: full-text access rights. DPDPA/HIPAA if individual patient data is involved.

Sources

  1. PRISMA 2020 — accessed 2026-04-20
  2. Cochrane Handbook — accessed 2026-04-20
  3. ICMJE — accessed 2026-04-20